RTIs account for around 60% of global antibiotic prescribing and are a key driver of AMR
Related Posts
FDA approves new Alzheimer’s treatment regimen
Patients and care partners may find once every four weeks maintenance dosing easier The US Food and Drug Administration (FDA) has approved a new dosing […]
Quantum leap – PharmaTimes
For life sciences organisations, the pressure to speed up the time to market of new drugs and therapies continues at pace, alongside the need to […]
Europe contributes over €750m to African Vaccines Manufacturing Accelerator
The initiative aims to improve African pandemics, outbreaks, preparedness and responses The EU, its Member States and European financial institutions have announced a more than […]